Freeman Spogli Institute for International Studies Stanford University


FSI Stanford Publications


Image of Cover

International Study of Health Care Organization and Financing for End-Stage Renal Disease in France

Journal Article

Authors
Isabelle Durand-Zaleski - Stanford University
C Combe
P Lang

Published by
International Journal of Health Care Finance and Economics, Vol. 7 no. 2-3, page(s) 171-183
September 2007


The major features of ESRD management in France include the predominance of hemodialysis and the resulting competition for dialysis stations. In 2003, the prevalence of ESRD in France was 0.087%. Of the 52,000 ESRD patients, 30,882 were receiving dialysis and 21,233 had functioning renal transplants. The annual expenditure per ESRD patient in 2003 was estimated at euro40,975. Autodialysis, at euro49,133 per patient per year, was much less expensive than dialyzing in-center at either a public or private facility (euro111,006 and euro75,125, respectively). Transplant activity in France has rapidly increased in recent years, reaching 22 donors per million population in 2005.

Topics: Economics | France